These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 26949511)

  • 21. RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.
    Lee SH; Bae SC; Kim KW; Lee YM
    Oncogene; 2014 Mar; 33(11):1458-67. PubMed ID: 23542169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
    Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.
    Karsikas S; Myllymäki M; Heikkilä M; Sormunen R; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    J Mol Med (Berl); 2016 Mar; 94(3):301-10. PubMed ID: 26452676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.
    Takeda K; Cowan A; Fong GH
    Circulation; 2007 Aug; 116(7):774-81. PubMed ID: 17646578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
    Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
    Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice.
    Nunomiya A; Shin J; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Acta Physiol (Oxf); 2017 May; 220(1):99-112. PubMed ID: 27393382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.
    Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW
    Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetramethylpyrazine protects CoCl2-induced apoptosis in human umbilical vein endothelial cells by regulating the PHD2/HIF/1α-VEGF pathway.
    Yang C; Xu Y; Zhou H; Yang L; Yu S; Gao Y; Huang Y; Lu L; Liang X
    Mol Med Rep; 2016 Feb; 13(2):1287-96. PubMed ID: 26676934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.
    Takei A; Ekström M; Mammadzada P; Aronsson M; Yu M; Kvanta A; André H
    Sci Rep; 2017 Feb; 7():42546. PubMed ID: 28186209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.
    Chan DA; Sutphin PD; Yen SE; Giaccia AJ
    Mol Cell Biol; 2005 Aug; 25(15):6415-26. PubMed ID: 16024780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.
    Li L; Saliba P; Reischl S; Marti HH; Kunze R
    Neurobiol Dis; 2016 Jul; 91():221-35. PubMed ID: 27001147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
    Chen JX; Stinnett A
    Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α.
    Tan JT; Prosser HC; Vanags LZ; Monger SA; Ng MK; Bursill CA
    FASEB J; 2014 Jan; 28(1):206-17. PubMed ID: 24022405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.
    Kapitsinou PP; Rajendran G; Astleford L; Michael M; Schonfeld MP; Fields T; Shay S; French JL; West J; Haase VH
    Mol Cell Biol; 2016 May; 36(10):1584-94. PubMed ID: 26976644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.